PTEN is a crucial tumor suppressor gene inhibiting phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway, which is often aberrant in cancer [59]. This evidence concerns the gene AKT1 and neoplasm.